Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1
Public ClinicalTrials.gov record NCT04748705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blinded, Randomized, Placebo-Controlled, Phase 2B Trial of IMC-1 for the Treatment of Fibromyalgia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized, double-blind, placebo-controlled, 16-week study designed to explore the safety and efficacy of IMC-1 for the treatment of patients with fibromyalgia.
Study identification
- NCT ID
- NCT04748705
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 422 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 3, 2021 (Actual)
- Primary completion
- Aug 5, 2022 (Actual)
- Completion
- Aug 5, 2022 (Actual)
- Last update posted
- Sep 27, 2022
2021 – 2022
United States locations
- U.S. sites
- 42
- U.S. states
- 25
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IMC Study Site | Birmingham | Alabama | 35216 | — |
| IMC Study Site | Rogers | Arkansas | 72758 | — |
| IMC Study Site | Oceanside | California | 92056 | — |
| IMC Study Site | Riverside | California | 92503 | — |
| IMC Study Site | Sacramento | California | 95831 | — |
| IMC Study Site | San Diego | California | 92103 | — |
| IMC Study Site | Santa Ana | California | 92705 | — |
| IMC Study Site | Temecula | California | 92591 | — |
| IMC Study Site | Jacksonville | Florida | 32256 | — |
| IMC Study Site | Ocala | Florida | 34470 | — |
| IMC Study Site | Oldsmar | Florida | 34677 | — |
| IMC Study Site | Orlando | Florida | 32801 | — |
| IMC Study Site | Tampa | Florida | 33614 | — |
| IMC Study Site | Alpharetta | Georgia | 30022 | — |
| IMC Study Site | Gurnee | Illinois | 60031 | — |
| IMC Study Site | Evansville | Indiana | 47714 | — |
| IMC Study Site | Des Moines | Iowa | 50265 | — |
| IMC Study SIte | Prairie Village | Kansas | 66208 | — |
| IMC Study Site | Covington | Louisiana | 70433 | — |
| IMC Study Site | New Orleans | Louisiana | 70124 | — |
| IMC Study Site | Prairieville | Louisiana | 70769 | — |
| IMC Study Site | Boston | Massachusetts | 02131 | — |
| IMC Study Site | North Dartmouth | Massachusetts | 02747 | — |
| IMC Study Site | Jackson | Mississippi | 39202 | — |
| IMC Study Site | Las Vegas | Nevada | 89102 | — |
| IMC Study Site | Albuquerque | New Mexico | 87109 | — |
| IMC Study Site | Cedarhurst | New York | 11516 | — |
| IMC Study Site | Williamsville | New York | 14221 | — |
| IMC Study Site | Cincinnati | Ohio | 45219 | — |
| IMC Study Site | North Canton | Ohio | 44720 | — |
| IMC Study Site | Oklahoma City | Oklahoma | 73106 | — |
| IMC Study Site | Tulsa | Oklahoma | 74133 | — |
| IMC Study Site | Portland | Oregon | 97210 | — |
| IMC Study Site | Allentown | Pennsylvania | 18104 | — |
| IMC Study Site | Warwick | Rhode Island | 02886 | — |
| IMC Study Site | Chattanooga | Tennessee | 37421 | — |
| IMC Study Site | Knoxville | Tennessee | 37912 | — |
| IMC Study Site | Austin | Texas | 78737 | — |
| IMC Study Site | Dallas | Texas | 75231 | — |
| IMC Study Site | Salt Lake City | Utah | 84102 | — |
| IMC Study Site | Charlottesville | Virginia | 22911 | — |
| IMC Study Site | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04748705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04748705 live on ClinicalTrials.gov.